These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26238438)

  • 1. Targeting bone microenvironment: Clinical implications.
    Gnant M
    Breast; 2015 Nov; 24 Suppl 2():S49-50. PubMed ID: 26238438
    [No Abstract]   [Full Text] [Related]  

  • 2. New results from the use of bisphosphonates in cancer patients.
    Coleman R; Gnant M
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant bisphosphonates: a new standard of care?
    Gnant M
    Curr Opin Oncol; 2012 Nov; 24(6):635-42. PubMed ID: 23042123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates for breast cancer: questions answered, questions remaining.
    Layman R; Olson K; Van Poznak C
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):341-67. PubMed ID: 17512453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of bone loss induced by aromatase inhibitors.
    Gnant M
    Cancer Invest; 2006; 24(3):328-30. PubMed ID: 16809162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loving our bones.
    Sledge GW
    Clin Breast Cancer; 2009 May; 9(2):71. PubMed ID: 19433385
    [No Abstract]   [Full Text] [Related]  

  • 7. Routine adjuvant use of bisphosphonates in breast cancer arguments in favour and against.
    Diel I; Aebi S
    Crit Rev Oncol Hematol; 2010 Apr; 74 Suppl 1():S11-5. PubMed ID: 20427027
    [No Abstract]   [Full Text] [Related]  

  • 8. [Encounter of cancer cells with bone. Cancer treatment-induced bone loss : CTIBL].
    Takahashi S
    Clin Calcium; 2011 Mar; 21(3):447-53. PubMed ID: 21358067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer treatment-induced bone loss: pathophysiology and clinical perspectives.
    Brufsky AM
    Oncologist; 2008 Feb; 13(2):187-95. PubMed ID: 18305064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant bisphosphonates for early-stage breast cancer.
    Brufsky A
    Lancet Oncol; 2011 Jul; 12(7):610-1. PubMed ID: 21708345
    [No Abstract]   [Full Text] [Related]  

  • 11. Emerging role for bisphosphonates in cancer management.
    Chlebowski RT
    Breast Dis; 2011; 33(2):55-7. PubMed ID: 22142659
    [No Abstract]   [Full Text] [Related]  

  • 12. Bisphosphonates in the adjuvant treatment of early breast cancer: conclusion.
    Eiermann W
    Crit Rev Oncol Hematol; 2010 Apr; 74 Suppl 1():S16-7. PubMed ID: 20427028
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant bisphosphonates in patients with breast cancer: does the potency matter?
    Amoroso V; Petrelli F; Pedersini R; Simoncini EL; Clézardin P; Barni S; Berruti A
    Future Oncol; 2015; 11(21):2853-6. PubMed ID: 26403833
    [No Abstract]   [Full Text] [Related]  

  • 14. Denosumab an option for patients with bone metastasis from breast cancer.
    Barton MK
    CA Cancer J Clin; 2011; 61(3):135-6. PubMed ID: 21532096
    [No Abstract]   [Full Text] [Related]  

  • 15. Bisphosphonates in adjuvant treatment of early breast cancer.
    ; Harbeck N; von Minckwitz G; Thürlimann B
    Crit Rev Oncol Hematol; 2010 Apr; 74 Suppl 1():S1. PubMed ID: 20427026
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical implications of bisphosphonate for bone metastases of prostate cancer].
    Kitagawa Y; Konaka H; Mizokami A; Namiki M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():356-9. PubMed ID: 18161131
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biphosphonates in breast cancer--based on a Cochrane meta-analysis].
    Junker N; Nielsen DL; Kamby C
    Ugeskr Laeger; 2007 Sep; 169(37):3108-11. PubMed ID: 17877961
    [No Abstract]   [Full Text] [Related]  

  • 18. Zoledronic acid prevents cancer treatment-induced bone loss.
    Oncology (Williston Park); 2005 Mar; 19(3):390. PubMed ID: 15828553
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of zoledronic acid in the treatment of breast cancer].
    Chen J; Liu ZY; Zhao LJ
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):318-9. PubMed ID: 21575510
    [No Abstract]   [Full Text] [Related]  

  • 20. Aromatase inhibitors and bisphosphonates reduce deaths from breast cancer, studies show.
    Kmietowicz Z
    BMJ; 2015 Jul; 351():h4036. PubMed ID: 26209688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.